No Posts
SKN | Healthcare ETFs in Focus: Does Novo Nordisk’s Outlook Reset the GLP-1 Trade?
Shares of Novo Nordisk suffered a steep repricing after the company warned that 2026 sales
- Lior mor
- •
- 6 Min Read
- •
- 3 months ago
No Posts
Shares of Novo Nordisk suffered a steep repricing after the company warned that 2026 sales